Tumor beta2-microglobulin and HLA-A expression is increased by immunotherapy and can predict response to CIT in association with other biomarkers.

MLA

Reis, Bernhard, et al. “Tumor Beta2-Microglobulin and HLA-A Expression Is Increased by Immunotherapy and Can Predict Response to CIT in Association with Other Biomarkers.” Frontiers in Immunology, Mar. 2024, pp. 01-15. EBSCOhost, https://doi.org/10.3389/fimmu.2024.1285049.

APA

Reis, B., Attig, J., Dziadek, S., Graefe, N., Heller, A., Rieder, N., & Gomes, B. (2024). Tumor beta2-microglobulin and HLA-A expression is increased by immunotherapy and can predict response to CIT in association with other biomarkers. Frontiers in Immunology, 01-15. https://doi.org/10.3389/fimmu.2024.1285049

Chicago

Reis, Bernhard, Jan Attig, Sebastian Dziadek, Nico Graefe, Astrid Heller, Natascha Rieder, and Bruno Gomes. 2024. “Tumor Beta2-Microglobulin and HLA-A Expression Is Increased by Immunotherapy and Can Predict Response to CIT in Association with Other Biomarkers.” Frontiers in Immunology, March, 01-15. doi:10.3389/fimmu.2024.1285049.